People | June 06, 2022
APhA appoints Ilisa Bernstein Interim CEO
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
Subscribe To Our Newsletter & Stay Updated
